Effect of Transcutaneous Electrical Acupoint Stimulation on Obstetric Quality of Recovery-10 After Cesarean Section

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04917614

Enrollment

Registered

2021-06-08

Start date

2021-07-18

Completion date

2022-01-24

Last updated

2024-09-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recovery

Keywords

ObsQoR-10T, recovery, ceserean, postoperative

Brief summary

The primary aim of this prospective and randomized trial is to investigate the effect of TEAS on postoperative recovery using the Obstetric Quality of Recovery-10 questionnaire in patients undergoing elective cesarean section.

Detailed description

Acupoint stimulation is postulated to modulate neurological signal transmission through afferent nociceptive pathways. Acupoint stimulation has been associated with positive effects on perioperative symptoms such as nausea, pain, and sleep disturbance. Transcutaneous electrical acupuncture point stimulation (TEAS) is an acupuncture treatment developed by combining traditional Chinese acupuncture with transcutaneous electrical nerve stimulation. TEAS has proven to be effective in postoperative pain and nausea-vomiting by applying a current of different frequencies, intensities, and waveforms through electrodes adhering to the skin. Using TEAS may relieve perioperative symptoms without increasing the risk of drug-related adverse events and alleviate and improve the patient's health condition, including the postoperative perspective.

Interventions

DEVICETranscutaneous Electrical Acupoint Stimulation

Transcutaneous Electrical Acupoint Stimulation

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 48 Years

Healthy volunteers

Yes

Inclusion criteria

* Elective cesarean operation * Able to give informed consent

Exclusion criteria

* Patients with neurological or psychological diseases * patients with chronic analgesic and antidepressant drug use * Patients unable to communicate * Patients previously treated with TEAS or acupuncture, * Patients with heart failure and have pace-maker, * patient with local infection in the TEAS area

Design outcomes

Primary

Measure	Time frame	Description
Quality of Recovery	The first 24 hours postoperatively	Obstetric Quality of Recovery-10 (ObsQoR-10©) Scoring Tool

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026